VIATRIS INC. Income Taxes Receivable
VIATRIS INC. (VTRS) had Income Taxes Receivable of $543.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:IncomeTaxReceivable · last filed 2026-08-06
- 2026-06-30: Income Taxes Receivable $543.30M.
- 2026-03-31: Income Taxes Receivable $665.70M.
- 2025-12-31: Income Taxes Receivable $315.80M.
- 2025-09-30: Income Taxes Receivable $215.60M.
| Period end | Income Taxes Receivable |
|---|---|
| 2026-06-30 | $543.30M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $665.70M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $315.80M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $215.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $339.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $262.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $300.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $227.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $295.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $310.70M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $340.20M 10-K · filed 2025-02-27 |
| 2022-12-31 | $328.40M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |